Stock Events

Pacira BioSciences 

$28.19
17
+$0.85+3.11% Tuesday 20:00

Statistics

Day High
28.21
Day Low
27.21
52W High
41.65
52W Low
25.33
Volume
988,088
Avg. Volume
610,827
Mkt Cap
1.31B
P/E Ratio
21.36
Dividend Yield
-
Dividend
-

Earnings

7MayConfirmed
Q3 2022
Q4 2022
Q1 2023
Q2 2023
Q3 2023
Q4 2023
Q1 2024
0.53
0.65
0.77
0.89
Expected EPS
0.62
Actual EPS
0.62

People Also Follow

This list is based on the watchlists of people on Stock Events who follow PCRX. It's not an investment recommendation.

Competitors

This list is an analysis based on recent market events. It's not an investment recommendation.

Analyst Ratings

47.5$Average Price Target
The highest estimate is $57.
From 6 ratings within the last 6 months. This is not an investment recommendation.
Buy
100%
Hold
0%
Sell
0%

About

Health Technology
Pharmaceuticals: Other
Manufacturing
Pharmaceutical Preparation Manufacturing
Pacira BioSciences, Inc. provides non-opioid pain management and regenerative health solutions for healthcare practitioners and their patients in the United States. The company offers EXPAREL, a bupivacaine liposome injectable suspension; ZILRETTA, a triamcinolone acetonide extended-release injectable suspension; and iovera system, a non-opioid handheld cryoanalgesia device used to produce controlled doses of cold temperature only to targeted nerves. It also develops proprietary multivesicular liposome, a drug delivery technology that encapsulates drugs without altering their molecular structure. The company was formerly known as Pacira Pharmaceuticals, Inc. and changed its name to Pacira BioSciences, Inc. in April 2019. Pacira BioSciences, Inc. was incorporated in 2006 and is headquartered in Tampa, Florida.
Show more...
CEO
David M. Stack
Employees
711
Country
US
ISIN
US6951271005
WKN
000A1H68T

Listings